Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 14 November, NDCN's Autoimmune Neurology Group held an event for patients and public, to discuss the research on autoimmune encephalitis at the University of Oxford.

What is autoimmune encephalitis?

Autoimmune encephalitis is an illness affecting the brain. It can cause changes in thought, perception, and memory; seizures; and abnormal movements. In autoimmune encaphalitis, the immune system, which usually prevents infection, malfunctions. It turns against the brain via molecules called antibodies. 

The Oxford Autoimmune Neurology Group led by Sarosh Irani and Paddy Waters studies the cells which produce the antibodies, to work out which medications can destroy these cells and help reduce antibody levels.

What happened on the day?

The research team demystified what goes on in their lab, using a fun and interactive 'Ready Steady Assay!' demonstration based on a popular TV programme (see video below). Patients offered perspectives on their experiences of the condition, as well as what it is like to be involved in research. A representative from the Encephalitis Society explained the role of the charity, and there was an open forum on the future directions research in Oxford could take.

Huge thanks also for an amazingly informative and engaging day yesterday. It gave us all a much deeper understanding.
- Event attendee

How did it go?

All survey respondents strongly agreed or agreed that the event improved their knowledge about autoimmune encephalitis research in Oxford. They all said they would attend another similar event. Comments revealed that the most memorable part of the day was meeting other people affected by encephalitis, and hearing about the cutting-edge research going on here in Oxford.

Similar stories

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'

Discovery of gene involved in chronic pain creates new treatment target

Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.

Lymph nodes reveal more about mechanisms of autoimmunity

Two recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.